Appendix 2—table 5. Primary Analysis Cohort (Region=New York State), Patient Characteristics Pre/Post Match.
| Region=New York State Unmatched | Region=New York State Matched | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All | BP Non-users | BP Users | p-value | All | BP Non-users | BP Users | p-value | |||||||
| N | % | N | % | N | % | N | % | N | % | N | % | |||
| All Patients | 968,296 | 100.0% | 918,261 | 94.8% | 50,035 | 5.2% | 99,724 | 100.0% | 49,862 | 50.0% | 49,862 | 50.0% | ||
| Age | ||||||||||||||
| ≤20 | 133,178 | 13.8% | 133,128 | 14.5% | 50 | 0.1% | <0.001 | 102 | 0.1% | 52 | 0.1% | 50 | 0.1% | 1.00 |
| 21-40 | 192,959 | 19.9% | 192,731 | 21.0% | 228 | 0.5% | 453 | 0.5% | 225 | 0.5% | 228 | 0.5% | ||
| 41-50 | 127,794 | 13.2% | 127,139 | 13.8% | 655 | 1.3% | 1,311 | 1.3% | 656 | 1.3% | 655 | 1.3% | ||
| 51-60 | 172,444 | 17.8% | 166,080 | 18.1% | 6,364 | 12.7% | 12,732 | 12.8% | 6,368 | 12.8% | 6,364 | 12.8% | ||
| 61-70 | 159,912 | 16.5% | 143,776 | 15.7% | 16,136 | 32.2% | 32,265 | 32.4% | 16,129 | 32.3% | 16,136 | 32.4% | ||
| 71-80 | 120,117 | 12.4% | 102,655 | 11.2% | 17,462 | 34.9% | 34,693 | 34.8% | 17,352 | 34.8% | 17,341 | 34.8% | ||
| ≥81 | 61,892 | 6.4% | 52,752 | 5.7% | 9,140 | 18.3% | 18,168 | 18.2% | 9,080 | 18.2% | 9,088 | 18.2% | ||
| Gender | ||||||||||||||
| Female | 573,610 | 59.2% | 528,152 | 57.5% | 45,458 | 90.9% | <0.001 | 90,567 | 90.8% | 45,282 | 90.8% | 45,285 | 90.8% | 0.97 |
| Male | 394,686 | 40.8% | 390,109 | 42.5% | 4,577 | 9.1% | 9,157 | 9.2% | 4,580 | 9.2% | 4,577 | 9.2% | ||
| Insurance | ||||||||||||||
| Commercial | 500,918 | 51.7% | 490,503 | 53.4% | 10,415 | 20.8% | <0.001 | 20,830 | 20.9% | 10,415 | 20.9% | 10,415 | 20.9% | 1.00 |
| Dual | 6,814 | 0.7% | 5,218 | 0.6% | 1,596 | 3.2% | 3,154 | 3.2% | 1,581 | 3.2% | 1,573 | 3.2% | ||
| Medicaid | 252,366 | 26.1% | 243,191 | 26.5% | 9,175 | 18.3% | 18,044 | 18.1% | 9,019 | 18.1% | 9,025 | 18.1% | ||
| Medicare | 208,198 | 21.5% | 179,349 | 19.5% | 28,849 | 57.7% | 57,696 | 57.9% | 28,847 | 57.9% | 28,849 | 57.9% | ||
| PCP Visit 2019 | ||||||||||||||
| No | 521,282 | 53.8% | 502,609 | 54.7% | 18,673 | 37.3% | <0.001 | 37,253 | 37.4% | 18,616 | 37.3% | 18,637 | 37.4% | 0.89 |
| Yes | 447,014 | 46.2% | 415,652 | 45.3% | 31,362 | 62.7% | 62,471 | 62.6% | 31,246 | 62.7% | 31,225 | 62.6% | ||
| Continuous Outcomes | ||||||||||||||
| mean | SD | mean | SD | mean | SD | p-value | mean | SD | mean | SD | mean | SD | p-value | |
| CCI | 0.65 | 1.39 | 0.63 | 1.37 | 0.95 | 1.68 | <0.001 | 0.95 | 1.68 | 0.95 | 1.67 | 0.95 | 1.68 | 0.93 |
BP: bisphosphonate; CCI: Charlson Comorbidity Index; PCP: primary care physician; SD: standard deviation.